It can be noted from the presented data (Table 1) that there is no
unambiguous dependence of morbidity and detail indicator on population
density.
Experience with the COVID-19 pandemic since 11 March 2020 shows that
countries that introduced severe restrictive measures early in the
epidemic have significantly reduced or stabilized their infection
(morbidity) rates. Such countries include China, Russia, Germany, Norway
(morbidity per 100,000 population < 300 people), and the
countries that followed a ”liberal approach” to restrictive measures had
morbidity rates above 300/100,000 population (Italy, Spain, United
Kingdom). The absence of practically restrictive measures has led to a
significant increase in the incidence of diseases, as happened in Sweden
(>1,000/100,000 population).
There are other reasons for fluctuations in the incidence rate. These
include the loyalty of the population to the authorities, the
implementation by the vast majority of the population of measures aimed
at preventing the spread of infection. The need for mandatory
implementation of recommendations by citizens should be accompanied by
informing the population about the causes of the spread of infection and
possible consequences of the disease. It is important to have truthful
information based on the opinions of medical scientists, the maximum
exclusion of pseudo-scientific, previously false information about the
infection. The third aspect of this problem is the development of a
control system and analysis of the implementation of restrictive
measures. The state solves this issue in different ways and there can be
no right recipes for everyone.
In addition, long-term restrictive measures of isolation of citizens
cause fatigue, which leads to disregard for social distances, wearing
masks.
Rating of countries on the number of deaths from coronavirus infection
as of 18.04.2020 led the U.S., Britain, Italy, France, Spain, but in
calculating mortality - the situation is different. Belgium (16.37%),
France (16.64%), Great Britain (14.17%), Italy (14.15%), Hungary
(13.07%), Netherlands (12.90%), Sweden (12.21%), Spain (11.95%),
Mexico (10.52%), USA (5.1%), Germany (3.07%), Brazil (6.3%), Turkey
(2.16%), China (5.46%), Norway (1.31%), Russia (0.94%).
Table 2.
Comparative lethality rates in some countries for 18.04.2020 and
30.05.2020.